T1	Participants 106 138	elective hip-replacement surgery
T2	Participants 559 782	2275 consecutive patients aged 18 years or older who were undergoing elective hip-replacement surgery to receive postoperative subcutaneous injections of either 2.5 mg fondaparinux once daily or 30 mg enoxaparin twice daily
